L. Zibdawi

Phase II Multicenter Trial of Anthracycline Rechallenge With Pegylated Liposomal Doxorubicin Plus Cyclophosphamide for First-Line Therapy of Metastatic Breast Cancer Previously Treated With Adjuvant Anthracyclines

Maureen Trudeau, Mark Clemons, Louise Provencher et al. · Journal of Clinical Oncology · 2009 · 37 citations · Full text

Medicine, Oncology, Pharmacology +17

A multicentre, randomised trial comparing schedules of G-CSF (filgrastim) administration for primary prophylaxis of chemotherapy-induced febrile neutropenia in early stage breast cancer

Mark Clemons, Dean Fergusson, Demetrios Simos et al. · Annals of Oncology · 2020 · 37 citations

Pharmacy, Oncology, Pharmacotherapy +15

Rate of Egfr Mutation Testing for Patients with Nonsquamous Non-Small-Cell Lung Cancer with Implementation of Reflex Testing by Pathologists

Parneet Cheema, Simon Raphael, Robert H. El-Maraghi et al. · Current Oncology · 2017 · 31 citations · Full text

Medicine, Oncology, Cancer Screening +10

CheckMate 384: Phase IIIb/IV trial of nivolumab (nivo) 480 mg Q4W versus 240 mg Q2W after ≤ 12 months of nivo in previously treated advanced NSCLC.

Edward B. Garon, Niels Reinmuth, L. Falchero et al. · Journal of Clinical Oncology · 2019 · 22 citations

Pharmacy, Oncology, Pharmacology +17